The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression-Reference-Cited by-同舟云学术

The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression

Published:2012-02-13 Issue:46 Volume:31 Page:4878-4887
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Babbio F,Pistore C,Curti L,Castiglioni I,Kunderfranco P,Brino L,Oudet P,Seiler R,Thalman G N,Roggero E,Sarti M,Pinton S,Mello-Grand M,Chiorino G,Catapano C V,Carbone G M,Bonapace I M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011641.pdf

Reference50 articles.

1. Feinberg AP . The epigenetics of cancer etiology. Semin Cancer Biol 2004; 14: 427–432.

2. Perry AS, Watson RW, Lawler M, Hollywood D . The epigenome as a therapeutic target in prostate cancer. Nat Rev Urol 2010; 7: 668–680.

3. Jeronimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ et al. Epigenetics in prostate cancer: biologic and clinical relevance. Eur Urol 2011; 60: 753–766.

4. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624–629.

5. Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 2006; 24: 268–273.

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogenic Roles of UHRF1 in Cancer;Epigenomes;2024-07-01

2. UHRF1 poly-auto-ubiquitination induced by the anti-cancer drug, thymoquinone, is involved in the DNA repair machinery recruitment.;The International Journal of Biochemistry & Cell Biology;2024-06

3. The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-β signaling;Scientific Reports;2024-05-24

4. The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma;Oncogene;2024-01-04

5. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04